Business Context and Reporting Period
This Form 6-K filing by Bon Natural Life Ltd covers the month of September 2024. The report discloses a material transaction entered into on September 30, 2024, involving the company's operating subsidiary, Xi'an App-Chem Bio (Tech) Co., Ltd. ("App-Chem"), and its wholly owned subsidiary, Gansu Baimeikang Biotechnology Co., Ltd. ("Baimeikang").
Key Financial Metrics and Transaction Details
The filing details an Asset Selling Agreement with Xinjiang Baixiangquan Aromatic (Tech) Co., Ltd. ("Baixiangquan") for the sale of 100% of the equity interests in Baimeikang. The filing does not provide consolidated revenue, profit, cash flow, or debt metrics for the reporting period.
| Item | Value/Description |
|---|---|
| Total Transfer Price | RMB 43,307,700.00 |
| Assets Included | Land Use Rights (33,330 sqm in Yumen City), Construction in Progress, Advance Payments |
| Initial Deposit | RMB 300,000.00 (Due within 10 business days) |
| Payment Schedule | Phased payments through April 30, 2026 |
Material Changes and Payment Structure
The primary material change is the divestiture of Baimeikang assets. The transaction is structured as a phased equity transfer with the following payment milestones:
- Deposit: RMB 300,000.00 payable within 10 business days of execution.
- Equity Transfer: To be completed within 15 business days after the deposit payment.
- April 30, 2025: 20% of Transfer Price (RMB 8,661,540.00).
- October 30, 2025: 30% of Transfer Price (RMB 12,992,310.00).
- April 30, 2026: Remaining 50% of Transfer Price (RMB 21,353,850.00).
The Transfer Price covers the asset value but excludes taxes and fees, which are the responsibility of the buyer, Baixiangquan.
Guidance, Risks, and Contingencies
The filing does not provide specific financial guidance, outlook, or management commentary beyond the transaction summary. The document notes that the Agreement contains additional terms, covenants, and conditions that should be reviewed in the attached Exhibit 10.1. A key contingency is the successful completion of the equity transfer registration following the initial deposit.
Investor Verification Checklist
- Verify the execution of the Asset Selling Agreement and receipt of the RMB 300,000.00 deposit.
- Confirm the completion of the equity transfer registration for Baimeikang to Baixiangquan.
- Review the full text of Exhibit 10.1 for covenants, conditions precedent, and termination clauses.
- Monitor the scheduled payment milestones in 2025 and 2026 to ensure collection of the remaining RMB 43,007,700.00.
- Assess the impact of this divestiture on the company's future operational capacity and revenue streams.